These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33369477)

  • 1. Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer.
    De Castro TB; Rodrigues-Fleming GH; Oliveira-Cucolo JG; Silva JNGD; Silva FP; Raposo LS; Maniglia JV; Pavarino EC; Batista Arantes LMR; Galbiatti-Dias ALS; Maria Goloni Bertollo E
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3751-3759. PubMed ID: 33369477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3B C46359T and SHMT1 C1420T polymorphisms in the folate pathway in carcinogenesis of head and neck.
    Succi M; de Castro TB; Galbiatti AL; Arantes LM; da Silva JN; Maniglia JV; Raposo LS; Pavarino EC; Goloni-Bertollo EM
    Mol Biol Rep; 2014 Feb; 41(2):581-9. PubMed ID: 24362509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Polymorphisms in Genes Involved in One-Carbon Metabolism with
    Coppedè F; Stoccoro A; Tannorella P; Gallo R; Nicolì V; Migliore L
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma.
    Bezerra AM; Sant'Ana TA; Gomes AV; de Lacerda Vidal AK; Muniz MT
    Mol Biol Rep; 2014 Dec; 41(12):7737-42. PubMed ID: 25341694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Liu Z; Wang L; Wang LE; Sturgis EM; Wei Q
    Cancer Lett; 2008 Sep; 268(1):158-65. PubMed ID: 18455294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of the common polymorphisms in the folate-methionine pathway with retinoblastoma.
    Soleimani E; Saliminejad K; Akbari MT; Kamali K; Ahani A
    Ophthalmic Genet; 2016 Dec; 37(4):384-387. PubMed ID: 26914443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age on the association between p16CDKN2A methylation and DNMT3B polymorphism in head and neck carcinoma and patient survival.
    Farias LC; Fraga CA; De Oliveira MV; Silva TF; Marques-Silva L; Moreira PR; De-Paula AM; Gomez RS; Guimarães AL
    Int J Oncol; 2010 Jul; 37(1):167-76. PubMed ID: 20514408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma.
    Kawakita D; Matsuo K; Sato F; Oze I; Hosono S; Ito H; Watanabe M; Yatabe Y; Hanai N; Hasegawa Y; Tajima K; Murakami S; Tanaka H
    Ann Oncol; 2012 Jan; 23(1):186-192. PubMed ID: 21460376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
    Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study.
    Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN
    Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating
    Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
    World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study.
    Fan H; Zhang F; Hu J; Liu D; Zhao Z
    J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3B polymorphisms and risk of primary lung cancer.
    Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
    Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.
    Kucharczyk T; Krawczyk P; Powrózek T; Kowalski DM; Ramlau R; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Krzakowski M; Milanowski J
    Pathol Oncol Res; 2016 Jan; 22(1):49-56. PubMed ID: 26277606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma.
    Skibola CF; Forrest MS; Coppedé F; Agana L; Hubbard A; Smith MT; Bracci PM; Holly EA
    Blood; 2004 Oct; 104(7):2155-62. PubMed ID: 15198953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes.
    Lightfoot TJ; Skibola CF; Willett EV; Skibola DR; Allan JM; Coppede F; Adamson PJ; Morgan GJ; Roman E; Smith MT
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2999-3003. PubMed ID: 16365025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.
    Salimi S; Keshavarzi F; Mohammadpour-Gharehbagh A; Moodi M; Mousavi M; Karimian M; Sandoughi M
    Gene; 2017 Dec; 637():161-172. PubMed ID: 28943344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.